Detalhe da pesquisa
1.
The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study.
J Infect Dis
; 223(4): 581-588, 2021 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216906
2.
End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, Massachusetts.
PLoS One
; 16(6): e0252679, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34086775
3.
Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge.
Int J Infect Dis
; 99: 28-33, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32721528